Flavones contained in the diet, such as naringenin, at low concentrations, inhibit aromatase activity (CYP19) and therefore inhibit estrogen biosynthesis, exerting an antiestrogenic effect, which is important in breast and prostate cancers treatment [25,26]. This evidence concerns the gene CYP19A1 and prostate carcinoma.